Eric Morel

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Quality standards for preclinical research in cardio-oncology.

Quality standards for preclinical research in cardio-oncology.

Journal: European heart journal

Published: November 30, 2025

A case report on the design and implementation of a multinational blended intensive programme in clinical pharmacy practice.

A case report on the design and implementation of a multinational blended intensive programme in clinical pharmacy practice.

Journal: Currents in pharmacy teaching & learning

Published: August 07, 2025

Transcriptomic biomarkers related to cardiac disease in childhood cancer survivors: a case-control study.

Transcriptomic biomarkers related to cardiac disease in childhood cancer survivors: a case-control study.

Journal: European heart journal

Published: December 24, 2024

Influence of genetic biomarkers on cardiac diseases in childhood cancer survivors: a systematic review.

Influence of genetic biomarkers on cardiac diseases in childhood cancer survivors: a systematic review.

Journal: The pharmacogenomics journal

Published: December 22, 2023

EPAC1 inhibition protects the heart from doxorubicin-induced toxicity.

EPAC1 inhibition protects the heart from doxorubicin-induced toxicity.

Journal: eLife

Published: September 29, 2022

Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity.

Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity.

Journal: Journal of molecular and cellular cardiology

Published: September 19, 2018

Specific Activation of the Alternative Cardiac Promoter of Cacna1c by the Mineralocorticoid Receptor.

Specific Activation of the Alternative Cardiac Promoter of Cacna1c by the Mineralocorticoid Receptor.

Journal: Circulation research

Published: November 24, 2017

Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.

Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.

Journal: Circulation

Published: November 06, 2014

Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis.

Epac contributes to cardiac hypertrophy and amyloidosis induced by radiotherapy but not fibrosis.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 30, 2013

Complications of chemotherapy, a basic science update.

Complications of chemotherapy, a basic science update.

Journal: Presse medicale (Paris, France : 1983)

Published: June 10, 2013

Complications of thoracic radiotherapy.

Complications of thoracic radiotherapy.

Journal: Presse medicale (Paris, France : 1983)

Published: June 10, 2013

Epac in cardiac calcium signaling.

Epac in cardiac calcium signaling.

Journal: Journal of molecular and cellular cardiology

Published: August 28, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026